Global Antitussive Drugs Market – Industry Trends and Forecast to 2030

Antitussive Drugs Market Analysis and Size

In recent years, the antitussive drugs market is anticipated to grow rapidly during the forecast period. Antitussive medications reduce coughing by decreasing cough activity and offering relief from dry cough. Antitussives come in various forms, including centrally acting antitussives, which include opioid derivatives, narcotics, non-opioids, and others. Local anaesthetics are antitussive drugs that work locally. Cough is a crucial defensive reflex symptom in health, but when it lasts for an extended period of time, people should seek medical help. Cough affects over 40% of the world's population at any given moment. Cough is most commonly caused by an upper respiratory tract infection, although cough can also be caused by pulmonary illnesses such as chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis, and lung cancer.

Data Bridge Market Research analyses that the global antitussive drugs market which was USD 1351.72 million in 2022, would rocket up to USD 1878.58 million by 2030, and is expected to undergo a CAGR of 4.20% during the forecast period. This indicates that the market value. “Hospitals" dominates the end segment of the antitussive drugs market due to increasing awareness for proper medication. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Market Definition

Cough suppressants, often known as antitussives, are drugs that prevent coughing. Although the specific mechanism of action is uncertain, antitussives are hypothesized to work by blocking a coordinating area for coughing in the brain stem, so breaking the cough reflex arc. Opioids are the source of many antitussives, including pholcodine, codeine, and dextromethorphan.

Antitussive Drugs Market Dynamics

Drivers

• Surging prevalence of cough

Cough is estimated to be a major element driving demand for antitussive drugs, which will propel the market forward. Cough is the most common reason for visits to primary care physicians worldwide, accounting for roughly 8% of all consultations, according to data published by the National Center for Biotechnology Information in 2014. According to the same source, the global annual prevalence of cough in the general population is estimated to be between 10% and 33%.

• Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of antitussive drugs market is the rising healthcare expenditure which helps in improving its infrastructure.

• Rising geriatric population

The surging number of geriatric population will propel the market's growth rate during the forecast period of 2022-2029. As per the World Ageing 2020 research, the world's population will be roughly 727 million people aged 65 and up in 2020. In 2050, the number of elderly people is expected to increase to 1.5 billion. The geriatric population is more prone to chronic ailments, which is anticipated to enhance the market's growth rate.

Opportunity

• Innovation and Drug Development:

Ongoing research and development in the pharmaceutical industry are leading to the discovery of novel antitussive compounds and formulations. The introduction of innovative drugs with improved efficacy and fewer side effects provides opportunities for pharmaceutical companies to capture market share and address unmet medical needs.

Restraint/Challenge

• Limited Efficacy and Side Effects

One significant restraint in the antitussive drugs market is the limited efficacy of many available medications, especially for chronic cough conditions. Cough is a natural reflex that helps clear the airways, and suppressing it entirely can lead to complications. Some antitussive drugs might not effectively address the underlying cause of the cough, leading to symptomatic relief without treating the root issue.

In addition, some antitussive medications can cause side effects such as drowsiness, constipation, dizziness, and nausea. These side effects can affect the patient's quality of life, leading to non-compliance or discontinuation of the medication. Patients, especially those with pre-existing health conditions or those taking multiple medications, might be hesitant to use antitussive drugs due to potential interactions and adverse effects. Furthermore, the overuse or misuse of antitussive medications, particularly those containing opioids, has raised concerns about addiction and abuse. Healthcare providers need to carefully weigh the benefits against the risks when prescribing these medications, leading to cautious use and limited prescription, acting as a restraint in the market. Complex regulatory processes and the need for compliance with diverse guidelines in different countries pose challenges for sponsors, leading to delays and increased costs.

This antitussive drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the antitussive drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In September 2021, Sun Pharmaceutical Industries Ltd. announced the launch of a novel formulation in cough management - Chericof 12 (Dextromethorphan Hydrobromide 30 mg and Chlorpheniramine Maleate 4 mg) in India. Chericof 12, India's first prescription cough syrup that provides relief for up to 12 hours, is made with Polistirex technology for long-term medication release. Chericof 12 is only for individuals who are six years old or older

Global Antitussive Drugs Market Scope

The antitussive drugs market is segmented on the basis of drug, drug class, indication, product type, age group, dosage form, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drug

• Benzonatate
• Dextromethorphan

Drug Class

• Centrally Acting Drugs
  • Opioids
  • Non-opioids
• Peripherally Acting Drugs
  • Phenoxdiazine
  • Others
• Others

Route of Administration

• Oral
• Inhalational
• Others

Dosage Form

• Syrup
• Tablet
• Others

Indication

• Cold Symptoms
• Pain
• Cough
• Others

Product Type

• Over-the-counter (OTC)
• Prescription Drug

Age Group

• Pediatric
• Adult
• Geriatric

End-Users

• Hospitals
• Specialty Clinics
• Homecare
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Global Antitussive Drugs Market Regional Analysis/Insights

Clinical trials market is analyzed and market size insights and trends are provided by country, drug, drug class, indication, product type, age group, dosage form, route of administration, end-users and distribution channel as referenced above.

The countries covered in the antitussive drugs market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, U.A.E, Egypt, Israel, rest of Middle East & Africa.

North America is expected to dominate the antitussive drugs market due to the use of the growing geriatric population and over use of unhealthy food in this region. In addition, the surging number of initiatives taken by the pharmaceutical organizations to generate novel formulation mainly for pediatric population and rising healthcare expenditure will further propel the market's growth rate in this region.

Asia-Pacific is expected to grow during the forecast period due to surging government initiatives to spread awareness and increasing the geriatric population in this region. Also, the development of healthcare infrastructure will further propel the market's growth rate in this region.

The country section of the report also provides individual market impacting factors and domestic regulation changes that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Healthcare Infrastructure growth Installed base and New Technology Penetration

The antitussive drugs market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Antitussive Drugs market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on Antitussive Drugs market. The data is available for historic period 2010-2020.

Competitive Landscape and Antitussive Drugs Market Share Analysis

The antitussive drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to antitussive drugs market.

Some of the major players operating in the antitussive drugs market are:

• F. Hoffmann-La Roche Ltd. (Switzerland)
• Mylan N.V. (U.S.)
• Teva Pharmaceutical Industries Ltd.(Israel)
• Sanofi (France), Pfizer Inc. (U.S.)
• GlaxoSmithKline plc (U.K.)
• Novartis AG (Switzerland)
• Sun Pharmaceutical Industries Ltd. (India)
• Amneal Pharmaceuticals LLC. (U.S.)
• Zydus Cadila (India)
• Aurobindo Pharma (India)
• Cipla Inc. (U.S.)
• Hikma Pharmaceuticals PLC (U.K.)
• AstraZeneca (U.K.)
• Johnson & Johnson Private Limited (U.S.)
• Intas Pharmaceuticals Ltd. (India)
• 3M (U.S.)
• Bayer AG (Germany)
• Ipca Laboratories Ltd. (India)
• Unique Pharmaceuticals Limited. (India)
• Aceto (U.S.) 

SKU-53928